Pages that link to "Q33468422"
Jump to navigation
Jump to search
The following pages link to Protection and polyfunctional T cells induced by Ag85B-TB10.4/IC31 against Mycobacterium tuberculosis is highly dependent on the antigen dose (Q33468422):
Displaying 50 items.
- Immune mechanisms of protection: can adjuvants rise to the challenge? (Q21245319) (← links)
- Tuberculosis vaccine types and timings (Q26862762) (← links)
- Testing the H56 Vaccine Delivered in 4 Different Adjuvants as a BCG-Booster in a Non-Human Primate Model of Tuberculosis (Q27327288) (← links)
- The HyVac4 subunit vaccine efficiently boosts BCG-primed anti-mycobacterial protective immunity (Q28727776) (← links)
- A comparative analysis of polyfunctional T cells and secreted cytokines induced by Bacille Calmette-Guérin immunisation in children and adults (Q28729028) (← links)
- Novel vaccination strategies against tuberculosis. (Q30363188) (← links)
- Cellular immune responses to nine Mycobacterium tuberculosis vaccine candidates following intranasal vaccination (Q31028998) (← links)
- The TB vaccine H56 IC31 dose-response curve is peaked not saturating: Data generation for new mathematical modelling methods to inform vaccine dose decisions (Q31141086) (← links)
- Role of 4-1BB receptor in the control played by CD8( ) T cells on IFN-gamma production by Mycobacterium tuberculosis antigen-specific CD4( ) T Cells (Q33900380) (← links)
- The novel tuberculosis vaccine, AERAS-402, induces robust and polyfunctional CD4 and CD8 T cells in adults (Q33950119) (← links)
- Variation in gamma interferon responses to different infecting strains of Mycobacterium tuberculosis in acid-fast bacillus smear-positive patients and household contacts in Antananarivo, Madagascar (Q33962683) (← links)
- CD4 and CD8 T-cell responses to mycobacterial antigens in African children (Q33988111) (← links)
- Aerosol vaccination with AERAS-402 elicits robust cellular immune responses in the lungs of rhesus macaques but fails to protect against high-dose Mycobacterium tuberculosis challenge (Q33992101) (← links)
- Dose of incorporated immunodominant antigen in recombinant BCG impacts modestly on Th1 immune response and protective efficiency against Mycobacterium tuberculosis in mice. (Q34053027) (← links)
- Immune subdominant antigens as vaccine candidates against Mycobacterium tuberculosis (Q34146613) (← links)
- The Secreted Lipoprotein, MPT83, of Mycobacterium tuberculosis Is Recognized during Human Tuberculosis and Stimulates Protective Immunity in Mice (Q34261521) (← links)
- Evaluation of the safety and immunogenicity of two antigen concentrations of the Mtb72F/AS02(A) candidate tuberculosis vaccine in purified protein derivative-negative adults (Q34289930) (← links)
- Surface expression of MPT64 as a fusion with the PE domain of PE_PGRS33 enhances Mycobacterium bovis BCG protective activity against Mycobacterium tuberculosis in mice (Q34309667) (← links)
- Rv3615c is a highly immunodominant RD1 (Region of Difference 1)-dependent secreted antigen specific for Mycobacterium tuberculosis infection. (Q34804956) (← links)
- Characterization of biomolecular nanoconjugates by high-throughput delivery and spectroscopic difference. (Q34971975) (← links)
- Prime-boost with Mycobacterium smegmatis recombinant vaccine improves protection in mice infected with Mycobacterium tuberculosis (Q35046608) (← links)
- Development of New Vaccines and Drugs For TB: Limitations and Potential Strategic Errors (Q35065531) (← links)
- CONTINUOUS REPOPULATION OF LYMPHOCYTE SUBSETS IN TRANSPLANTED MYCOBACTERIAL GRANULOMAS. (Q35547585) (← links)
- Intracellular Cytokine Staining and Flow Cytometry: Considerations for Application in Clinical Trials of Novel Tuberculosis Vaccines (Q35772893) (← links)
- B Cells and Programmed Death-Ligand 2 Signaling Are Required for Maximal Interferon-γ Recall Response by Splenic CD4⁺ Memory T Cells of Mice Vaccinated with Mycobacterium tuberculosis Ag85B. (Q35778676) (← links)
- Vaccine Potentiation by Combination Adjuvants (Q35826767) (← links)
- A high ratio of IC31(®) adjuvant to antigen is necessary for H4 TB vaccine immunomodulation (Q35887582) (← links)
- Recombinant adenovirus delivery of calreticulin-ESAT-6 produces an antigen-specific immune response but no protection against a Mycobacterium tuberculosis challenge. (Q35919921) (← links)
- Evaluation of the Immunogenicity of Mycobacterium bovis BCG Delivered by Aerosol to the Lungs of Macaques (Q35998753) (← links)
- Characterization of the HCMV-Specific CD4 T Cell Responses that Are Associated with Protective Immunity (Q36076246) (← links)
- Filarial infection suppresses malaria-specific multifunctional Th1 and Th17 responses in malaria and filarial coinfections (Q36125714) (← links)
- Improvement of BCG protective efficacy with a novel chimpanzee adenovirus and a modified vaccinia Ankara virus both expressing Ag85A (Q36369598) (← links)
- Mycolic acid-specific T cells protect against Mycobacterium tuberculosis infection in a humanized transgenic mouse model (Q36479685) (← links)
- Different human vaccine adjuvants promote distinct antigen-independent immunological signatures tailored to different pathogens (Q36500269) (← links)
- IL-10 inhibits mature fibrotic granuloma formation during Mycobacterium tuberculosis infection (Q36673887) (← links)
- A randomized, controlled dose-finding Phase II study of the M72/AS01 candidate tuberculosis vaccine in healthy PPD-positive adults (Q37301506) (← links)
- Increased TNF-α/IFN-γ/IL-2 and Decreased TNF-α/IFN-γ Production by Central Memory T Cells Are Associated with Protective Responses against Bovine Tuberculosis Following BCG Vaccination (Q37342751) (← links)
- T cell susceptibility to HIV influences outcome of opportunistic infections (Q37382387) (← links)
- Sprouty-2 regulates HIV-specific T cell polyfunctionality. (Q37410609) (← links)
- Alternative BCG delivery strategies improve protection against Mycobacterium tuberculosis in non-human primates: Protection associated with mycobacterial antigen-specific CD4 effector memory T-cell populations (Q37433271) (← links)
- Optimized subunit vaccine protects against experimental leishmaniasis (Q37439440) (← links)
- Polyfunctional and IFN-γ monofunctional human CD4 T cell populations are molecularly distinct. (Q37624370) (← links)
- Principles of vaccine design-Lessons from nature (Q37780346) (← links)
- Liposomal vaccine delivery systems (Q37854063) (← links)
- Immune markers and correlates of protection for vaccine induced immune responses (Q38015625) (← links)
- Novel particulate vaccines utilizing polyester nanoparticles (bio-beads) for protection against Mycobacterium bovis infection - a review (Q38109348) (← links)
- The candidate tuberculosis vaccine Mtb72F/AS02 in PPD positive adults: a randomized controlled phase I/II study (Q38460087) (← links)
- The two component adjuvant IC31® potentiates the protective immunity induced by a dengue 2 recombinant fusion protein in mice (Q38905825) (← links)
- Global Efforts in the Development of Vaccines for Tuberculosis: Requirements for Improved Vaccines Against Mycobacterium tuberculosis (Q38907507) (← links)
- Distinct polyfunctional CD4 T cell responses to BCG, ESAT-6 and CFP-10 in tuberculous pleurisy (Q39176024) (← links)